Oxyntomodulin biotin analogue

The present invention relates to a novel class of oxyntomodulin prostacyclin analogues, show a double GCGR and GLP-1R agonist activity, high hydrolysis stability, high biological activity, no adverse fat should occur, may be used for treating hyperphagia , obesity and overweight, high cholesterol and diabetes drugs.